Ehrlichia effector SLiM-icry: Artifice of cellular subversion
Frontiers in Cellular and Infection Microbiology · 07.03.2023 · 13
DOI: 10.3389/fcimb.2023.1150758 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 07.03.2023. Verfasst von Nicholas A Pittner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States. Hauptthemen laut MEDLINE: Host-Pathogen Interactions, Ehrlichia chaffeensis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, University of Texas Medical Branch at Galveston.
Abstract (Originalsprache)
As an obligately intracellular bacterial pathogen that selectively infects the mononuclear phagocyte, Ehrlichia chaffeensis has evolved sophisticated mechanisms to subvert innate immune defenses. While the bacterium accomplishes this through a variety of mechanisms, a rapidly expanding body of evidence has revealed that E. chaffeensis has evolved survival strategies that are directed by the versatile, intrinsically disordered, 120 kDa tandem repeat protein (TRP120) effector. E. chaffeensis establishes infection by manipulating multiple evolutionarily conserved cellular signaling pathways through effector-host interactions to subvert innate immune defenses. TRP120 activates these pathways using multiple functionally distinct, repetitive, eukaryote-mimicking short linear motifs (SLiMs) located within the tandem repeat domain that have evolved in nihilo . Functionally, the best characterized TRP120 SLiMs mimic eukaryotic ligands (SLiM-icry) to engage pathway-specific host receptors and activate cellular signaling, thereby repurposing these pathways to promote infection. Moreover, E. chaffeensis TRP120 contains SLiMs that are targets of post-translational modifications such as SUMOylation in addition to many other validated SLiMs that are curated in the eukaryotic linear motif (ELM) database. This review will explore the extracellular and intracellular roles TRP120 SLiM-icry plays during infection - mediated through a variety of SLiMs - that enable E. chaffeensis to subvert mononuclear phagocyte innate defenses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States.
- Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.
- Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, United States.
- Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, United States.
- Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, United States.
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- University of Texas Medical Branch at Galveston
- National Institutes of Health
Zitieren
APA
Pittner, N. A., Solomon, R. N., Bui, D. C., & McBride, J. W. (2023). Ehrlichia effector SLiM-icry: Artifice of cellular subversion. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1150758
Vancouver
Pittner NA, Solomon RN, Bui DC, McBride JW. Ehrlichia effector SLiM-icry: Artifice of cellular subversion. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1150758
BibTeX
@article{Pittner2023,
author = {Pittner, Nicholas A and Solomon, Regina N and Bui, Duc-Cuong and McBride, Jere W},
title = {Ehrlichia effector SLiM-icry: Artifice of cellular subversion},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
volume = {13},
doi = {10.3389/fcimb.2023.1150758}
}
EUVIMED